Now there are two: Modern’s mRNA COVID-19 vaccine 94.5% successful, joins Pfizer-BioNTech collaboration in targeting pandemic

Print Friendly, PDF & Email
screen shot at am
Credit: Photo Illustration by Rafael Henrique/SOPA Images/LightRocket via Getty Images

The Moderna vaccine reduced the risk of Covid-19 infection by 94.5%. There were 95 cases of infection among patients who received placebo in the company’s 30,000-patient study. There were only five infections in patients who developed Covid-19 after receiving Moderna’s vaccine, mRNA-1273.

Moderna also released data about the number of patients who had severe Covid-19. There were 11 cases of severe disease, all of them in the placebo group — … [a] point of encouragement for [Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases].

“There was always the concern … since the primary endpoint [of the trial] is just clinically apparent disease, how do we know it’s going to have an impact on severe disease? And the results with severe disease were striking — 11 to zero is very impressive,” he said. At the time of their data release, Pfizer and BioNTech had no severe cases in their study.

Related article:  Tetanus infection offers ‘gut-wrenching’ warning about dangers of not vaccinating children

Further, Fauci said the Moderna vaccine appears to have been protective in important subsets of participants — the elderly and people from racial and ethnic minority groups, the latter of which make up 37% of the Moderna trial population.

The Moderna vaccine is given in two doses, 28 days apart.

Read the original post

Outbreak Featured
Infographic: Autoimmune diseases — 76 identified so far — tend to target women over men. Here is a master list

Infographic: Autoimmune diseases — 76 identified so far — tend to target women over men. Here is a master list

There are many autoimmune diseases, and taken together they affect as much as 4.5 percent of the world’s population. This ...
Are GMOs and pesticides threatening bees?

Are GMOs and pesticides threatening bees?

First introduced in 1995, neonicotinoids ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.